Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 1, 2002, Pages 105-111

  Ireson, Christopher R ^a   Jones, Donald J L ^a   Boocock, David J ^a   Farmer, Peter B ^a   Gescher, Andreas J ^a   Orr, Samantha ^b   Coughtrie, Michael W H ^c   Williams, Marion L ^a   Steward, William P ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; ANTINEOPLASTIC AGENT; ARYL SULFOTRANSFERASE; CURCUMIN; CURCUMIN GLUCURONIDE; CURCUMIN SULFATE; HEXAHYDROCURCUMIN; ISOENZYME; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; CURCUMA LONGA; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DETERMINATION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTESTINE; LIVER CYTOSOL; LIVER MICROSOME METABOLISM; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADULT; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; BLOTTING, WESTERN; CHEMOPREVENTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CULTURE TECHNIQUES; CURCUMIN; CYTOSOL; FEMALE; HUMANS; INTESTINES; LIVER; MALE; MASS SPECTROMETRY; MICROSOMES; MIDDLE AGED; RATS; RATS, INBRED F344; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

EID: 0036160713     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Strategy and planning for chemopreventive drug development: Clinical development plans II
2. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occuring plant phenolic compound
3. Chemopreventive effect of curcumina naturally occurring anti-inflammatory agent, during the promotion/progression stage of colon cancer
4. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis
5. Antioxidant activity of curcumin and related compounds
6. Diminution of singlet oxygen induced DNA damage by curcumin and related antioxidants
7. Studies on curcumin and curcuminoids. XXII: Curcumin as a reducing agent and as a radical scavenger
8. Oxygen radical scavenging activity of curcumin
9. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron
10. Cytotoxic and cytoprotective activities of curcumin: Effects on paracetamol-induced cytotoxicity, lipid peroxidation and glutathione depletion in rat hepatocytes
11. Anti-inflammatory and irritant activities of curcumin analogues in rats
12. Lipid peroxide formation in experimental inflammation
13. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoylphorbol-13-acetate in NIH 3T3 cells
14. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cell
15. Inhibitory effects of curcumin on tumor promotion and arachidonic acid metabolism in mouse epidermis
16. Inhibitory effect of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis
17. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signaling complex
18. Characterization of metabolites of the chemopreventive agent curcumin in humans and rat hepatocytes and in rat plasma and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production
19. Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer
20. Biotransformation of curcumin through reduction and glucuronidation in mice
21. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma
22. Involvement of the β-diketone moiety in the antioxidant mechanism of tetrahydrocurcumin
23. Antioxidative activity of tetrahydrocurcuminoids
24. In vitro studies on the intestinal absorption of curcumin in rats
25. A hydroxysteroid sulfotransferase from rat liver
26. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of α-hydroxytamoxifen in vitro: A metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts
27. Identification of human cytochrome P450 analogous to forms induced by phenobarbital and 3-methylcholanthrene in the rat
28. The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface
29. Sulfation of thyroid hormone and dopamine during human development-ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung and brain
30. Dopamine sulphate: An enigma resolved
31. Review. First-pass metabolism by the gastrointestinal mucosa
32. Relation of structure of curcumin analogs to their potencies as inducers of phase 2 detoxification enzymes
33. Effects of curcumin, demethocycurcumin, bisdemetheoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol13-acetate-induced tumor promotion